Overview

PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers

Status:
Completed
Trial end date:
2008-11-28
Target enrollment:
Participant gender:
Summary
The present pharmacokinetic study is designed to further characterise the pharmacokinetics of the RSG XR formulation and aims to assess dose proportionality, strength equivalence, the food effect and the pharmacokinetics after repeat dosing.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Rosiglitazone